Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population
Identifieur interne : 000898 ( Pmc/Checkpoint ); précédent : 000897; suivant : 000899Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population
Auteurs : Sara L. Gale [États-Unis] ; Huong Trinh [États-Unis] ; Nitya Mathew [États-Unis] ; Angelika Jahreis [États-Unis] ; Celia J. F. Lin [États-Unis] ; Khaled Sarsour [États-Unis]Source :
- Rheumatology and Therapy [ 2198-6576 ] ; 2019.
Abstract
Real-world use of immunomodulating therapy (IMT) in patients with systemic sclerosis (SSc) was investigated for the first time in a descriptive, retrospective cohort analysis of claims made in a healthcare insurance database to characterize treatment patterns and their alignment with SSc disease manifestations.
Treatment patterns and disease manifestations, symptoms, complications, and comorbidities were assessed in patients with SSc enrolled in a US healthcare claims database who received treatment between January 2006 and December 2013 and for whom data were available 6 months before and 12 months after SSc diagnosis.
Among 7812 eligible patients, 6852 received treatments of interest for SSc and 2404 (30.8%) received IMT during the first year after SSc diagnosis. In the first year after diagnosis, the most common claims were for antibiotics (61.7%), opioids (50.6%), glucocorticoids (46.5%), and proton pump inhibitors (35.4%); the most common organs involved with complications among patients with SSc were lung (30.5%), heart (17.4%), and gastrointestinal tract (22.4%); the most common signs or symptoms were musculoskeletal (16.1%) and fatigue (10.5%); 1035 patients (15.1%) had infections and 14 (0.2%) had malignancies. Among patients who received IMT, 43.8% received at least hydroxychloroquine and 21.1% received at least methotrexate; 460 patients switched to a second IMT, 23.0% to at least methotrexate and 22.8% to at least mycophenolate mofetil. The most common comorbidities reported with first IMT were in lung (11.8%), overlap syndrome (8.4%), heart (5.3%), and gastrointestinal (6.8%) categories.
One-third of patients with SSc in the healthcare claims population received IMTs during the first year after diagnosis. However, patients who received IMTs had disease manifestations similar to those of the overall SSc healthcare claims population.
The online version of this article (10.1007/s40744-019-00181-8) contains supplementary material, which is available to authorized users.
Url:
DOI: 10.1007/s40744-019-00181-8
PubMed: 31734871
PubMed Central: 7021840
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:7021840Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population</title>
<author><name sortKey="Gale, Sara L" sort="Gale, Sara L" uniqKey="Gale S" first="Sara L." last="Gale">Sara L. Gale</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Trinh, Huong" sort="Trinh, Huong" uniqKey="Trinh H" first="Huong" last="Trinh">Huong Trinh</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mathew, Nitya" sort="Mathew, Nitya" uniqKey="Mathew N" first="Nitya" last="Mathew">Nitya Mathew</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Jahreis, Angelika" sort="Jahreis, Angelika" uniqKey="Jahreis A" first="Angelika" last="Jahreis">Angelika Jahreis</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lin, Celia J F" sort="Lin, Celia J F" uniqKey="Lin C" first="Celia J. F." last="Lin">Celia J. F. Lin</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sarsour, Khaled" sort="Sarsour, Khaled" uniqKey="Sarsour K" first="Khaled" last="Sarsour">Khaled Sarsour</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">31734871</idno>
<idno type="pmc">7021840</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021840</idno>
<idno type="RBID">PMC:7021840</idno>
<idno type="doi">10.1007/s40744-019-00181-8</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000170</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000170</idno>
<idno type="wicri:Area/Pmc/Curation">000170</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000170</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000898</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000898</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population</title>
<author><name sortKey="Gale, Sara L" sort="Gale, Sara L" uniqKey="Gale S" first="Sara L." last="Gale">Sara L. Gale</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Trinh, Huong" sort="Trinh, Huong" uniqKey="Trinh H" first="Huong" last="Trinh">Huong Trinh</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mathew, Nitya" sort="Mathew, Nitya" uniqKey="Mathew N" first="Nitya" last="Mathew">Nitya Mathew</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Jahreis, Angelika" sort="Jahreis, Angelika" uniqKey="Jahreis A" first="Angelika" last="Jahreis">Angelika Jahreis</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lin, Celia J F" sort="Lin, Celia J F" uniqKey="Lin C" first="Celia J. F." last="Lin">Celia J. F. Lin</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Sarsour, Khaled" sort="Sarsour, Khaled" uniqKey="Sarsour K" first="Khaled" last="Sarsour">Khaled Sarsour</name>
<affiliation wicri:level="2"><nlm:aff id="Aff1">Genentech, South San Francisco, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Genentech, South San Francisco</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Rheumatology and Therapy</title>
<idno type="ISSN">2198-6576</idno>
<idno type="eISSN">2198-6584</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Introduction</title>
<p id="Par1">Real-world use of immunomodulating therapy (IMT) in patients with systemic sclerosis (SSc) was investigated for the first time in a descriptive, retrospective cohort analysis of claims made in a healthcare insurance database to characterize treatment patterns and their alignment with SSc disease manifestations.</p>
</sec>
<sec><title>Methods</title>
<p id="Par2">Treatment patterns and disease manifestations, symptoms, complications, and comorbidities were assessed in patients with SSc enrolled in a US healthcare claims database who received treatment between January 2006 and December 2013 and for whom data were available 6 months before and 12 months after SSc diagnosis.</p>
</sec>
<sec><title>Results</title>
<p id="Par3">Among 7812 eligible patients, 6852 received treatments of interest for SSc and 2404 (30.8%) received IMT during the first year after SSc diagnosis. In the first year after diagnosis, the most common claims were for antibiotics (61.7%), opioids (50.6%), glucocorticoids (46.5%), and proton pump inhibitors (35.4%); the most common organs involved with complications among patients with SSc were lung (30.5%), heart (17.4%), and gastrointestinal tract (22.4%); the most common signs or symptoms were musculoskeletal (16.1%) and fatigue (10.5%); 1035 patients (15.1%) had infections and 14 (0.2%) had malignancies. Among patients who received IMT, 43.8% received at least hydroxychloroquine and 21.1% received at least methotrexate; 460 patients switched to a second IMT, 23.0% to at least methotrexate and 22.8% to at least mycophenolate mofetil. The most common comorbidities reported with first IMT were in lung (11.8%), overlap syndrome (8.4%), heart (5.3%), and gastrointestinal (6.8%) categories.</p>
</sec>
<sec><title>Conclusion</title>
<p id="Par4">One-third of patients with SSc in the healthcare claims population received IMTs during the first year after diagnosis. However, patients who received IMTs had disease manifestations similar to those of the overall SSc healthcare claims population.</p>
</sec>
<sec><title>Electronic Supplementary Material</title>
<p>The online version of this article (10.1007/s40744-019-00181-8) contains supplementary material, which is available to authorized users.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Nikpour, M" uniqKey="Nikpour M">M Nikpour</name>
</author>
<author><name sortKey="Stevens, Wm" uniqKey="Stevens W">WM Stevens</name>
</author>
<author><name sortKey="Herrick, Al" uniqKey="Herrick A">AL Herrick</name>
</author>
<author><name sortKey="Proudman, Sm" uniqKey="Proudman S">SM Proudman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Ioannidis, Jp" uniqKey="Ioannidis J">JP Ioannidis</name>
</author>
<author><name sortKey="Vlachoyiannopoulos, Pg" uniqKey="Vlachoyiannopoulos P">PG Vlachoyiannopoulos</name>
</author>
<author><name sortKey="Haidich, Ab" uniqKey="Haidich A">AB Haidich</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mayes, Md" uniqKey="Mayes M">MD Mayes</name>
</author>
<author><name sortKey="Lacey, Jv" uniqKey="Lacey J">JV Lacey</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mayes, Md" uniqKey="Mayes M">MD Mayes</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Furst, De" uniqKey="Furst D">DE Furst</name>
</author>
<author><name sortKey="Fernandes, Aw" uniqKey="Fernandes A">AW Fernandes</name>
</author>
<author><name sortKey="Iorga, Sr" uniqKey="Iorga S">SR Iorga</name>
</author>
<author><name sortKey="Greth, W" uniqKey="Greth W">W Greth</name>
</author>
<author><name sortKey="Bancroft, T" uniqKey="Bancroft T">T Bancroft</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Arias Nunez, Mc" uniqKey="Arias Nunez M">MC Arias-Nunez</name>
</author>
<author><name sortKey="Llorca, J" uniqKey="Llorca J">J Llorca</name>
</author>
<author><name sortKey="Vazquez Rodriguez, Tr" uniqKey="Vazquez Rodriguez T">TR Vazquez-Rodriguez</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Roberts Thomson, Pj" uniqKey="Roberts Thomson P">PJ Roberts-Thomson</name>
</author>
<author><name sortKey="Jones, M" uniqKey="Jones M">M Jones</name>
</author>
<author><name sortKey="Hakendorf, P" uniqKey="Hakendorf P">P Hakendorf</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Silman, A" uniqKey="Silman A">A Silman</name>
</author>
<author><name sortKey="Jannini, S" uniqKey="Jannini S">S Jannini</name>
</author>
<author><name sortKey="Symmons, D" uniqKey="Symmons D">D Symmons</name>
</author>
<author><name sortKey="Bacon, P" uniqKey="Bacon P">P Bacon</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Geirsson, Aj" uniqKey="Geirsson A">AJ Geirsson</name>
</author>
<author><name sortKey="Steinsson, K" uniqKey="Steinsson K">K Steinsson</name>
</author>
<author><name sortKey="Guthmundsson, S" uniqKey="Guthmundsson S">S Guthmundsson</name>
</author>
<author><name sortKey="Sigurthsson, V" uniqKey="Sigurthsson V">V Sigurthsson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Andreasson, K" uniqKey="Andreasson K">K Andreasson</name>
</author>
<author><name sortKey="Saxne, T" uniqKey="Saxne T">T Saxne</name>
</author>
<author><name sortKey="Bergknut, C" uniqKey="Bergknut C">C Bergknut</name>
</author>
<author><name sortKey="Hesselstrand, R" uniqKey="Hesselstrand R">R Hesselstrand</name>
</author>
<author><name sortKey="Englund, M" uniqKey="Englund M">M Englund</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hoffmann Vold, Am" uniqKey="Hoffmann Vold A">AM Hoffmann-Vold</name>
</author>
<author><name sortKey="Midtvedt, O" uniqKey="Midtvedt O">O Midtvedt</name>
</author>
<author><name sortKey="Molberg, O" uniqKey="Molberg O">O Molberg</name>
</author>
<author><name sortKey="Garen, T" uniqKey="Garen T">T Garen</name>
</author>
<author><name sortKey="Gran, Jt" uniqKey="Gran J">JT Gran</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chifflot, H" uniqKey="Chifflot H">H Chifflot</name>
</author>
<author><name sortKey="Fautrel, B" uniqKey="Fautrel B">B Fautrel</name>
</author>
<author><name sortKey="Sordet, C" uniqKey="Sordet C">C Sordet</name>
</author>
<author><name sortKey="Chatelus, E" uniqKey="Chatelus E">E Chatelus</name>
</author>
<author><name sortKey="Sibilia, J" uniqKey="Sibilia J">J Sibilia</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Khanna, D" uniqKey="Khanna D">D Khanna</name>
</author>
<author><name sortKey="Distler, Jhw" uniqKey="Distler J">JHW Distler</name>
</author>
<author><name sortKey="Sandner, P" uniqKey="Sandner P">P Sandner</name>
</author>
<author><name sortKey="Distler, O" uniqKey="Distler O">O Distler</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Denton, Cp" uniqKey="Denton C">CP Denton</name>
</author>
<author><name sortKey="Hughes, M" uniqKey="Hughes M">M Hughes</name>
</author>
<author><name sortKey="Gak, N" uniqKey="Gak N">N Gak</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kowal Bielecka, O" uniqKey="Kowal Bielecka O">O Kowal-Bielecka</name>
</author>
<author><name sortKey="Fransen, J" uniqKey="Fransen J">J Fransen</name>
</author>
<author><name sortKey="Avouac, J" uniqKey="Avouac J">J Avouac</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Pope, Je" uniqKey="Pope J">JE Pope</name>
</author>
<author><name sortKey="Bellamy, N" uniqKey="Bellamy N">N Bellamy</name>
</author>
<author><name sortKey="Seibold, Jr" uniqKey="Seibold J">JR Seibold</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Tashkin, Dp" uniqKey="Tashkin D">DP Tashkin</name>
</author>
<author><name sortKey="Elashoff, R" uniqKey="Elashoff R">R Elashoff</name>
</author>
<author><name sortKey="Clements, Pj" uniqKey="Clements P">PJ Clements</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hoyles, Rk" uniqKey="Hoyles R">RK Hoyles</name>
</author>
<author><name sortKey="Ellis, Rw" uniqKey="Ellis R">RW Ellis</name>
</author>
<author><name sortKey="Wellsbury, J" uniqKey="Wellsbury J">J Wellsbury</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Tashkin, Dp" uniqKey="Tashkin D">DP Tashkin</name>
</author>
<author><name sortKey="Roth, Md" uniqKey="Roth M">MD Roth</name>
</author>
<author><name sortKey="Clements, Pj" uniqKey="Clements P">PJ Clements</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Burt, Rk" uniqKey="Burt R">RK Burt</name>
</author>
<author><name sortKey="Shah, Sj" uniqKey="Shah S">SJ Shah</name>
</author>
<author><name sortKey="Dill, K" uniqKey="Dill K">K Dill</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Van Laar, Jm" uniqKey="Van Laar J">JM van Laar</name>
</author>
<author><name sortKey="Farge, D" uniqKey="Farge D">D Farge</name>
</author>
<author><name sortKey="Sont, Jk" uniqKey="Sont J">JK Sont</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Walker, Km" uniqKey="Walker K">KM Walker</name>
</author>
<author><name sortKey="Pope, J" uniqKey="Pope J">J Pope</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sakkas, Li" uniqKey="Sakkas L">LI Sakkas</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Shah, Aa" uniqKey="Shah A">AA Shah</name>
</author>
<author><name sortKey="Wigley, Fm" uniqKey="Wigley F">FM Wigley</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nihtyanova, Si" uniqKey="Nihtyanova S">SI Nihtyanova</name>
</author>
<author><name sortKey="Ong, Vh" uniqKey="Ong V">VH Ong</name>
</author>
<author><name sortKey="Denton, Cp" uniqKey="Denton C">CP Denton</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kowal Bielecka, O" uniqKey="Kowal Bielecka O">O Kowal-Bielecka</name>
</author>
<author><name sortKey="Landewe, R" uniqKey="Landewe R">R Landewe</name>
</author>
<author><name sortKey="Avouac, J" uniqKey="Avouac J">J Avouac</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Pope, J" uniqKey="Pope J">J Pope</name>
</author>
<author><name sortKey="Harding, S" uniqKey="Harding S">S Harding</name>
</author>
<author><name sortKey="Khimdas, S" uniqKey="Khimdas S">S Khimdas</name>
</author>
<author><name sortKey="Bonner, A" uniqKey="Bonner A">A Bonner</name>
</author>
<author><name sortKey="Baron, M" uniqKey="Baron M">M Baron</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Alharbi, S" uniqKey="Alharbi S">S Alharbi</name>
</author>
<author><name sortKey="Ahmad, Z" uniqKey="Ahmad Z">Z Ahmad</name>
</author>
<author><name sortKey="Bookman, Aa" uniqKey="Bookman A">AA Bookman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bosello, S" uniqKey="Bosello S">S Bosello</name>
</author>
<author><name sortKey="De Santis, M" uniqKey="De Santis M">M De Santis</name>
</author>
<author><name sortKey="Lama, G" uniqKey="Lama G">G Lama</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Daoussis, D" uniqKey="Daoussis D">D Daoussis</name>
</author>
<author><name sortKey="Melissaropoulos, K" uniqKey="Melissaropoulos K">K Melissaropoulos</name>
</author>
<author><name sortKey="Sakellaropoulos, G" uniqKey="Sakellaropoulos G">G Sakellaropoulos</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Khanna, D" uniqKey="Khanna D">D Khanna</name>
</author>
<author><name sortKey="Denton, Cp" uniqKey="Denton C">CP Denton</name>
</author>
<author><name sortKey="Jahreis, A" uniqKey="Jahreis A">A Jahreis</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Distler, O" uniqKey="Distler O">O Distler</name>
</author>
<author><name sortKey="Highland, Kb" uniqKey="Highland K">KB Highland</name>
</author>
<author><name sortKey="Gahlemann, M" uniqKey="Gahlemann M">M Gahlemann</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Rheumatol Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">Rheumatol Ther</journal-id>
<journal-title-group><journal-title>Rheumatology and Therapy</journal-title>
</journal-title-group>
<issn pub-type="ppub">2198-6576</issn>
<issn pub-type="epub">2198-6584</issn>
<publisher><publisher-name>Springer Healthcare</publisher-name>
<publisher-loc>Cheshire</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">31734871</article-id>
<article-id pub-id-type="pmc">7021840</article-id>
<article-id pub-id-type="publisher-id">181</article-id>
<article-id pub-id-type="doi">10.1007/s40744-019-00181-8</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group><article-title>Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7556-8990</contrib-id>
<name><surname>Gale</surname>
<given-names>Sara L.</given-names>
</name>
<address><email>gale.sara@gene.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Trinh</surname>
<given-names>Huong</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Mathew</surname>
<given-names>Nitya</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Jahreis</surname>
<given-names>Angelika</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lin</surname>
<given-names>Celia J. F.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author"><name><surname>Sarsour</surname>
<given-names>Khaled</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1">Genentech, South San Francisco, CA USA</aff>
</contrib-group>
<pub-date pub-type="epub"><day>16</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>16</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection"><month>3</month>
<year>2020</year>
</pub-date>
<volume>7</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>99</lpage>
<history><date date-type="received"><day>9</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions><copyright-statement>© The Author(s) 2019</copyright-statement>
</permissions>
<abstract id="Abs1"><sec><title>Introduction</title>
<p id="Par1">Real-world use of immunomodulating therapy (IMT) in patients with systemic sclerosis (SSc) was investigated for the first time in a descriptive, retrospective cohort analysis of claims made in a healthcare insurance database to characterize treatment patterns and their alignment with SSc disease manifestations.</p>
</sec>
<sec><title>Methods</title>
<p id="Par2">Treatment patterns and disease manifestations, symptoms, complications, and comorbidities were assessed in patients with SSc enrolled in a US healthcare claims database who received treatment between January 2006 and December 2013 and for whom data were available 6 months before and 12 months after SSc diagnosis.</p>
</sec>
<sec><title>Results</title>
<p id="Par3">Among 7812 eligible patients, 6852 received treatments of interest for SSc and 2404 (30.8%) received IMT during the first year after SSc diagnosis. In the first year after diagnosis, the most common claims were for antibiotics (61.7%), opioids (50.6%), glucocorticoids (46.5%), and proton pump inhibitors (35.4%); the most common organs involved with complications among patients with SSc were lung (30.5%), heart (17.4%), and gastrointestinal tract (22.4%); the most common signs or symptoms were musculoskeletal (16.1%) and fatigue (10.5%); 1035 patients (15.1%) had infections and 14 (0.2%) had malignancies. Among patients who received IMT, 43.8% received at least hydroxychloroquine and 21.1% received at least methotrexate; 460 patients switched to a second IMT, 23.0% to at least methotrexate and 22.8% to at least mycophenolate mofetil. The most common comorbidities reported with first IMT were in lung (11.8%), overlap syndrome (8.4%), heart (5.3%), and gastrointestinal (6.8%) categories.</p>
</sec>
<sec><title>Conclusion</title>
<p id="Par4">One-third of patients with SSc in the healthcare claims population received IMTs during the first year after diagnosis. However, patients who received IMTs had disease manifestations similar to those of the overall SSc healthcare claims population.</p>
</sec>
<sec><title>Electronic Supplementary Material</title>
<p>The online version of this article (10.1007/s40744-019-00181-8) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en"><title>Keywords</title>
<kwd>Databases</kwd>
<kwd>Immunosuppressive agents</kwd>
<kwd>Patterns of care</kwd>
<kwd>Systemic sclerosis</kwd>
<kwd>Scleroderma</kwd>
</kwd-group>
<funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007013</institution-id>
<institution>F. Hoffmann-La Roche</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Gale, Sara L" sort="Gale, Sara L" uniqKey="Gale S" first="Sara L." last="Gale">Sara L. Gale</name>
</region>
<name sortKey="Jahreis, Angelika" sort="Jahreis, Angelika" uniqKey="Jahreis A" first="Angelika" last="Jahreis">Angelika Jahreis</name>
<name sortKey="Lin, Celia J F" sort="Lin, Celia J F" uniqKey="Lin C" first="Celia J. F." last="Lin">Celia J. F. Lin</name>
<name sortKey="Mathew, Nitya" sort="Mathew, Nitya" uniqKey="Mathew N" first="Nitya" last="Mathew">Nitya Mathew</name>
<name sortKey="Sarsour, Khaled" sort="Sarsour, Khaled" uniqKey="Sarsour K" first="Khaled" last="Sarsour">Khaled Sarsour</name>
<name sortKey="Trinh, Huong" sort="Trinh, Huong" uniqKey="Trinh H" first="Huong" last="Trinh">Huong Trinh</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000898 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000898 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:7021840 |texte= Characterizing Disease Manifestations and Treatment Patterns Among Adults with Systemic Sclerosis: A Retrospective Analysis of a US Healthcare Claims Population }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:31734871" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ChloroquineV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |